FKBP5 has been extensively investigated in the context of neurological disorders, such as post‐traumatic stress disorder (PTSD), Alzheimer's disease (AD), and Parkinson's disease (PD) [18, 30, 31, 32, 33]. This evidence concerns the gene FKBP5 and early-onset autosomal dominant Alzheimer disease.